Content area
Tarsus Pharmaceuticals Inc (TARS) - Pharmaceuticals and Healthcare Product Pipeline
Summary
Tarsus Pharmaceuticals Inc (Tarsus Pharmaceuticals) is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics. The company’s pipeline products include TP-03, TP-04 and TP-05. Its pipeline treats meibomian gland disease, rosacea disease, lyme disease and malaria. Tarsus Pharmaceuticals also carries out Xdemvy for the treatment of demodex blepharitis, an eyelid margin disease characterized by inflammation, redness and ocular irritation.
This report provides outline on pipeline products by Number of Pipeline Products by Therapy Area, Indication, development stage and Partnered/Out-Licensed Products.
This report is built using information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.